Phoenix Financial’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$712K Buy
1,267
+117
+10% +$75K 0.01% 263
2025
Q4
$778K Buy
1,150
+90
+8% +$61.3K 0.01% 250
2025
Q3
$677K Sell
1,060
-121
-10% -$73.4K 0.01% 262
2025
Q2
$633K Buy
1,181
+20
+2% +$9.56K 0.01% 267
2025
Q1
$489K Buy
1,161
+32
+3% +$13.9K 0.01% 258
2024
Q4
$467K Sell
1,129
-10
-0.9% -$4.39K 0.01% 267
2024
Q3
$576K Buy
1,139
+227
+25% +$110K 0.01% 241
2024
Q2
$449K Buy
912
+23
+3% +$11.5K 0.01% 256
2024
Q1
$479K Sell
889
-22
-2% -$12K 0.01% 273
2023
Q4
$518K Buy
911
+142
+18% +$66.7K 0.01% 242
2023
Q3
$338K Buy
769
+21
+3% +$10.5K 0.01% 273
2023
Q2
$369K Sell
748
-12
-2% -$5.75K 0.01% 256
2023
Q1
$372K Sell
760
-268
-26% -$128K 0.01% 228
2022
Q4
$422K Sell
1,028
-75
-7% -$29.1K 0.01% 226
2022
Q3
$370K Buy
1,103
+332
+43% +$122K 0.01% 265
2022
Q2
$273K Sell
771
-63
-8% -$25.7K 0.01% 334
2022
Q1
$458K Sell
834
-9
-1% -$4.73K 0.01% 300
2021
Q4
$556K Sell
843
-60
-7% -$37.7K 0.01% 282
2021
Q3
$567K Buy
+903
New +$607K 0.01% 314
2021
Q2
Sell
-522
Closed -$248K 351
2021
Q1
$248K Buy
522
+32
+7% +$16K 0.01% 361
2020
Q4
$243K Buy
+490
New +$219K 0.01% 325
2020
Q3
Sell
-713
Closed -$224K 352
2020
Q2
$224K Buy
+713
New +$206K 0.01% 284

Other funds holding IDXX

Phoenix Financial's IDXX Position: Q1 2026 in Review

Phoenix Financial increased its Idexx Laboratories (IDXX) stake by 10% in Q1 2026, buying an estimated $75K and bringing the position to 1,267 shares worth $712K. The position accounts for 0.01% of the portfolio, ranked #263.

Phoenix Financial first reported a position in IDXX in Q2 2020 and has held it in 22 quarters since. The position peaked at $778K in Q4 2025. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Phoenix Financial held 1,267 shares of Idexx Laboratories worth $712K as of Q1 2026.
  • Phoenix Financial bought 117 Idexx Laboratories shares in Q1 2026, an estimated $75K.
  • Idexx Laboratories made up 0.01% of Phoenix Financial's portfolio in Q1 2026, its #263 holding.
  • Phoenix Financial first reported a position in Idexx Laboratories in Q2 2020 and has held it in 22 quarters since.
  • Phoenix Financial's Idexx Laboratories position peaked at $778K in Q4 2025.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.